Boston Scientific (NYSE: BSX) has more than doubled in value since early January 2021 – jumping from levels of $36 then to around $82 now – vs. an increase of about 45% for the S&P 500 over this period.
Boston Scientific Corporation (NYSE:BSX ) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:00 AM ET Company Participants Brad Sutton - Chief Medical Officer, AF Solutions Jon Monson - SVP, IR Michael F. Mahoney - Chairman and CEO Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Lawrence Biegelsen Okay.
Medical device maker Boston Scientific Corporation (BSX) shares rising on product, financial performance.
In the most recent trading session, Boston Scientific (BSX) closed at $81.79, indicating a +1.39% shift from the previous trading day.
BSX achieves CE Mark approval for the ACURATE Prime Aortic Valve System, its latest TAVR technology.
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here is how Boston Scientific (BSX) and Addex Therapeutics Ltd. Sponsored ADR (ADXN) have performed compared to their sector so far this year.
ServiceNow (NOW), Boston Scientific (BSX) and The Cooper Companies (COO) have been selected as the top picks with a high net income ratio.
Boston Scientific (BSX) withdraws its premerger notification and report form to give the U.S. FTC more time to review the proposed acquisition of Silk Road Medical.
Five old economy stocks with strong near-term potential are: NEM, GE, PFE, PGR, BSX.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?